Medical device development company Evolve Medtech Partners announced on Wednesday that Rob Abrams has joined the company's team.
With more than 30 years of experience in biomedical device product development, research, operational management, new business development and strategic investments, Abrams currently serves as a senior global business development and strategy executive with Kaneka Corp.
Abrams previously served as an operating partner at Sanderling Ventures and CEO of Pulsar Vascular, which was acquired by Johnson & Johnson.
Before he joined Sanderling, Abrams was group vice president of new business development for cardiovascular at Boston Scientific and has also served in various roles at Target Therapeutics, Localmed, Howmedica, and Guidant. lve-medtech.com
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
GSK's meningitis vaccine candidate accepted for FDA review
Innovent Biologics names new Oncology CMO
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
AbbVie announces interim evaluation of Atogepant Phase three, open-label 156-week extension study